Anthrax infection is rare but not remarkable in herbivores such as cattle, sheep, goats, camels, and antelopes. Anthrax can be found globally. It is more common in developing countries or countries without veterinary public health programs. Certain regions of the world (South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East) report more anthrax in animals than others.
| Table of contents |
|
2 Means of infection 3 Treatment and prevention 4 Description of the bacterium 5 Biological warfare 6 References 7 External links |
Exposure
When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products (such as skin and meat). Workers who are exposed to dead animals and animal products from countries where anthrax is more common may become infected with B. anthracis, and anthrax in wild livestock has occurred in the United States. Although many such workers are routinely exposed to significant levels of anthrax spores, most are not sufficiently exposed to develop symptoms.
Pulmonary (pneumonic, respiratory, inhalation) anthrax infection initially presents with cold or flu-like symptoms for several days, followed by severe (and often fatal) respiratory problems. If not treated soon after exposure, inhalation infection is the most deadly, with a nearly 100% mortality rate. A lethal case of anthrax is reported to result from inhaling 10,000-20,000 spores. This form of the disease has also been known as Woolsorters' disease. Other routes have included the slicing up of animal horns for the manufacture of buttons, and handling bristles used for the manufacturing of brushes.
Gastrointestinal (gastroenteric) anthrax infection often presents with serious gastrointestinal difficulty, vomiting of blood, and severe diarrhea. Untreated, intestinal infection results in a 25-60% death rate.
Cutaneous (skin) anthrax infection presents with a large, painless necrotic ulcer (beginning as a irritating and itchy skin lesion or blister which is dark in color, usually concentrated as a black dot, somewhat resembling bread mold) at the site of infection, forming about a week or two after exposure. Unlike bruises or most other lesions, cutaneous anthrax does not cause pain. Cutaneous infection is the least deadly; without treatment, approximately 20% of all skin infection cases are fatal. Treated cutaneous anthrax is rarely fatal.
Treatment and prevention
Treatment for anthrax infections includes large doses of intravenous and oral antibiotics, such as penicillin, ciprofloxacin, erythromycin, and vancomycin. For inhalation cases, antibiotic treatment is not very effective if initiated more than 24 hours after infection, after symptoms appear. Antibiotic prophylaxis is crucial in cases of pulmonary anthrax to save lives. Some antibiotic-resistant strains are known.
A vaccine, produced from one component of the toxin of a non-virulent strand, is also available. The vaccine must be given at least four weeks before exposure to anthrax; annual booster injections are required to maintain immunity.
The spores can be trapped with a simple HEPA or P100 filter. Anthrax as an airborne threat can be prevented with a full-face mask. Unbroken skin is decontaminated simply with soap and water.
Bacillus anthracis is a rod-size gram-positive bacterium of size about 1 by 6 microns. It was the first bacterium ever to be shown to cause disease, by Robert Koch in 1877. The bacteria normally rest in spore form in the soil, and can survive for decades in this state. Once taken in by an herbivore, the bacteria start multiplying inside the animal and eventually kill it, then continue to reproduce in the carcass. Once they run out of nutrients there, they revert back to the dormant spore state.
The infection of herbivores (and humans) proceeds as follows: the spore is located and engulfed by scavenger cells of the immune system specialized to deal with invaders. Inside the scavenger cell, the spore turns into a bacillus, multiplies, and eventually bursts the cell, releasing bacilli into the bloodstream. There they release a protein toxin which has macrophages as its principal target. The toxin has two components: edema factor and lethal factor. Edema factor inactivates macrophages so that they cannot participate in the fight against the infection; lethal factor causes the macrophage to make TNF-alpha and interleukin-1-beta, both normal components of the immune system used to induce an inflammatory reaction. The excessive inflammation throughout the body ultimately leads to septic shock and death.
The virulence of a strain of anthrax is dependent on its enclosing capsule and its toxin; the two are determined by different genes.
British tests in 1942 contaminated Gruinard Island in Scotland with anthrax spores, and rendered it unusable for the following 48 years. An accidental release of anthrax in a research lab at Fort Detrick in Frederick, Maryland in the United States led to the permanent sealing of a building with plastics and glues.
The simplest method of obtaining an anthrax sample would be to get it from an animal killed by anthrax; this source is rare in developed countries but common in underdeveloped countries.
Cultivating anthrax spores takes minimal equipment and about a first-year collegiate microbiological education. However, to make an aerosol form of anthrax suitable for biological warfare requires extensive training and highly developed equipment. The major problem is to prevent the spores from forming clumps too large for effective infection.
Description of the bacterium
Biological warfare
Spores of this bacteria can be used in biological warfare. US Army personnel are now routinely vaccinated prior to active service in places where biological attacks are considered a threat. The anthrax vaccine, produced by BioPort Corporation, contains no live bacteria, and is approximately 93% effective in preventing infection. Anthrax vaccination is one of many factors suspected of causing Gulf War syndrome.References
External links